Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre

DNA mismatch repair complex is involved in the maintenance of DNA stability. In the recent years, a plethora of technical approaches for microsatellite instability (MSI) analysis emerged. Here, we review the results of our MSI status evaluation by adopting a customised workflow on microfluidic system obtained in 4 years of diagnostic routine practice. Data from MSI status were retrieved from our institutional archive covering the period from January 2017 to December 2021. Microfluidic analysis was carried out on microfluidic platform. Results were inspected with a proprietary software. Overall, microsatellite stability (MSS) and MSI-high (MSI-H) profile was detected in n=423/458 (92.36%) and n=35/458 (7.64%) patients with metastatic CRC (mCRC), respectively. In addition, n=78/86 (90.70%) and n=8/86 (9.30%) patients without CRC showed an MSS and MSI-H profile. This review highlights the suitability of microfluidic approach in patients with cancer for MSI testing.

[1]  M. Fassan,et al.  Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting , 2021, Cells.

[2]  J. Toh,et al.  A Simple, Accurate and Cost-Effective Capillary Electrophoresis Test with Computational Methods to Aid in Universal Microsatellite Instability Testing , 2021, Cells.

[3]  P. Gibbs,et al.  Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer. , 2020, The New England journal of medicine.

[4]  M. Fassan,et al.  Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study , 2020, Cells.

[5]  A. Scarpa,et al.  ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  F. Staroz,et al.  Microsatellite instability diagnosis using the fully automated Idylla platform: feasibility study of an in-house rapid molecular testing ancillary to immunohistochemistry in pathology laboratories , 2019, Journal of Clinical Pathology.

[7]  M. Fassan,et al.  Microfluidic chip technology applied to fine‐needle aspiration cytology samples for IGH clonality assessment , 2019, Diagnostic cytopathology.

[8]  K. Stefánsson,et al.  Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome , 2019, Journal of Medical Genetics.

[9]  P. Keegan,et al.  FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors , 2019, Clinical Cancer Research.

[10]  N. Lee,et al.  The therapeutic significance of mutational signatures from DNA repair deficiency in cancer , 2018, Nature Communications.

[11]  X. Qian,et al.  Comparison of microsatellite status detection methods in colorectal carcinoma. , 2018, International journal of clinical and experimental pathology.

[12]  G. Troncone,et al.  Microsatellite instability evaluation by automated microfluidic electrophoresis: an update , 2016, Journal of Clinical Pathology.

[13]  G. Troncone,et al.  EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer , 2015, Journal of Clinical Pathology.

[14]  R. Broaddus,et al.  Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. , 2014, Cancer genetics.

[15]  G. Troncone,et al.  EGFR mutation detection by microfluidic technology: a validation study , 2013, Journal of Clinical Pathology.

[16]  Helen M. Moore,et al.  Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue. , 2011, Archives of pathology & laboratory medicine.

[17]  J. Shia.  Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. , 2008, The Journal of molecular diagnostics : JMD.

[18]  P. Modrich,et al.  DNA mismatch repair: functions and mechanisms. , 2006, Chemical reviews.

[19]  R. Houlston,et al.  Systematic review of microsatellite instability and colorectal cancer prognosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.